Silvant Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,560
| Closed | -$270K | – | 332 |
|
|
2022
Q3 | $270K | Hold |
3,560
| – | – | 0.02% | 177 |
|
|
2022
Q2 | $247K | Hold |
3,560
| – | – | 0.06% | 138 |
|
|
2022
Q1 | $295K | Hold |
3,560
| – | – | 0.06% | 146 |
|
|
2021
Q4 | $267K | Sell |
3,560
-228
| -6% | -$17.1K | 0.05% | 161 |
|
|
2021
Q3 | $440K | Hold |
3,788
| – | – | 0.08% | 127 |
|
|
2021
Q2 | $840K | Sell |
3,788
-967
| -20% | -$214K | 0.13% | 102 |
|
|
2021
Q1 | $629K | Sell |
4,755
-781
| -14% | -$103K | 0.11% | 113 |
|
|
2020
Q4 | $958K | Hold |
5,536
| – | – | 0.16% | 97 |
|
|
2020
Q3 | $616K | Hold |
5,536
| – | – | 0.12% | 106 |
|
|
2020
Q2 | $328K | Hold |
5,536
| – | – | 0.06% | 132 |
|
|
2020
Q1 | $373K | Hold |
5,536
| – | – | 0.08% | 116 |
|
|
2019
Q4 | $467K | Hold |
5,536
| – | – | 0.09% | 117 |
|
|
2019
Q3 | $414K | Hold |
5,536
| – | – | 0.08% | 117 |
|
|
2019
Q2 | $350K | Hold |
5,536
| – | – | 0.06% | 140 |
|
|
2019
Q1 | $267K | Hold |
5,536
| – | – | 0.05% | 165 |
|
|
2018
Q4 | $185K | Buy |
5,536
+1,270
| +30% | +$42.4K | 0.04% | 184 |
|
|
2018
Q3 | $224K | Buy |
+4,266
| New | +$224K | 0.03% | 185 |
|